Yoshihiro Ohue

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Current Topics of Cancer Antigen

Current Topics of Cancer Antigen

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 22, 2019

Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

Journal: Cancer science
Published: March 06, 2019

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 16, 2019

Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.

Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: October 17, 2017

NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC.

NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: March 25, 2017

Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.

Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.

Journal: Lung
Published: December 01, 2016

Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.

Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.

Journal: Cancer immunology research
Published: October 27, 2015

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 03, 2015

Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.

Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.

Journal: Lung
Published: February 19, 2015

Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.

Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 10, 2015

Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).

Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 18, 2014

Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients.

Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients.

Journal: Oncoimmunology
Published: September 21, 2014
Showing 1-12 of 19

Last Updated: 09/26/2026